Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03152383 · ClinicalTrials.gov registry record · NA
Examination of Differential Valuation of Leisure Items and Attention as Reinforcers in Children With Autism
A NA study of Autism, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT03152383: Completed NA study of Autism, sponsored by Emory University.
NCT03152383 is a NA study of Autism that has completed, run by Emory University. The registered enrollment target is 64 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03152383, a NA study of Autism, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare how children with autism, typically developing children, and children with other developmental delays value social attention and toys. The first part of the study seeks to determine whether breakpoints when responding on progressive ratio (PR) schedules can be used to determine the value of leisure items and attention. By comparing the breakpoints obtained for leisure items and attention, the researchers will determine the differential valuation of leisure items and attention. It is anticipated that the manner in which individuals with an autism spectrum disorder (ASD) diagnosis and those who do not will differ with respect to the degree to which they value these two types of stimuli. The second part of the study seeks to determine whether an intervention in which social attention is paired with primary reinforcers impacts responding during the PR assessment, in children with ASD.
Primary Outcome
The highest schedule requirement completed (i.e., breakpoint) is used as a measure of how much an individual is willing to respond for a given stimulus.
Conditions Studied
Interventions
- BEHAVIORAL Training trials
- BEHAVIORAL Progressive Ratio Session
- BEHAVIORAL Re-test
- BEHAVIORAL Pairing Protocol
Study Locations (1)
Georgia
- Marcus Autism Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2012-06-22 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
What the finished NCT03152383 record still lists
NCT03152383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 4 interventions - of which Training trials is the first listed.
NCT03152383 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03152383 about?
NCT03152383 is a clinical study titled "Examination of Differential Valuation of Leisure Items and Attention as Reinforcers in Children With Autism". The purpose of this study is to compare how children with autism, typically developing children, and children with other developmental delays value social attention and toys. The first part of the study seeks to determine whether breakpoints when responding on progressive ratio (PR) schedules can be...
What is the current status of trial NCT03152383?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2012-06-22. Estimated completion is 2020-12-31.
What conditions does trial NCT03152383 study?
This clinical trial studies the following conditions: Autism.
What interventions are being tested in trial NCT03152383?
The interventions under investigation include: Training trials (BEHAVIORAL), Progressive Ratio Session (BEHAVIORAL), Re-test (BEHAVIORAL), Pairing Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT03152383?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03152383 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03152383's enrollment target sits among peer trials
64 52nd of 104 higher than 53 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI